Technical Analysis for ASND - Ascendis Pharma A/S

Grade Last Price % Change Price Change
grade B 139.13 -0.95% -1.34
ASND closed down 0.95 percent on Friday, January 17, 2020, on 82 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical ASND trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Outside Day Range Expansion 0.00%
180 Bullish Setup Bullish Swing Setup -0.95%
Slingshot Bullish Bullish Swing Setup -0.95%
NR7 Range Contraction -0.95%
Multiple of Ten Bullish Other -0.95%
Up 3 Days in a Row Strength -0.95%
Up 4 Days in a Row Strength -0.95%
Shooting Star Candlestick Bearish -0.05%
Lizard Bearish Bearish Day Trade Setup -0.05%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Ascendis Pharma A/S, a clinical stage biopharmaceutical company, develops various prodrug therapies to treat unmet medical needs. It is developing TransCon human growth hormone that has completed Phase II clinical trials in adults to treat growth hormone deficiency (GHD) and other indications, as well as in Phase II studies in children for treating GHD; and TransCon Treprostinil for the treatment of pulmonary arterial hypertension, a life-threatening disease characterized by elevated blood pressure in the pulmonary arteries. The company is also developing TransCon Insulin for the treatment of diabetes; and TransCon Ranibizumab, a compound to support ranibizumab injection. It has strategic collaborations with Sanofi, Genentech, and United Therapeutics Corporation. The company was founded in 2006 and is headquartered in Hellerup, Denmark.
Biotechnology Life Sciences Disease Diabetes Hormones Pulmonary Arterial Hypertension Peptide Hormones Treatment Of Diabetes Breakthrough Therapy Genentech Recombinant Proteins Treprostinil

Is ASND a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 142.94
52 Week Low 66.115
Average Volume 262,963
200-Day Moving Average 115.51
50-Day Moving Average 122.63
20-Day Moving Average 135.94
10-Day Moving Average 137.93
Average True Range 4.69
ADX 34.27
+DI 28.11
-DI 15.12
Chandelier Exit (Long, 3 ATRs ) 128.88
Chandelier Exit (Short, 3 ATRs ) 131.59
Upper Bollinger Band 144.34
Lower Bollinger Band 127.55
Percent B (%b) 0.69
BandWidth 12.35
MACD Line 5.21
MACD Signal Line 5.68
MACD Histogram -0.4729
Fundamentals Value
Market Cap 4.52 Billion
Num Shares 32.5 Million
EPS -3.61
Price-to-Earnings (P/E) Ratio -38.54
Price-to-Sales 288.07
Price-to-Book 6.90
PEG Ratio -0.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 146.95
Resistance 3 (R3) 147.00 144.44 145.64
Resistance 2 (R2) 144.44 142.45 144.41 145.21
Resistance 1 (R1) 141.78 141.22 140.51 141.74 144.78
Pivot Point 139.23 139.23 138.59 139.20 139.23
Support 1 (S1) 136.57 137.24 135.29 136.52 133.48
Support 2 (S2) 134.02 136.01 133.99 133.05
Support 3 (S3) 131.36 134.02 132.62
Support 4 (S4) 131.31